{"id":"NCT02399345","sponsor":"AbbVie","briefTitle":"Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults","officialTitle":"An Open-Label, Treatment Duration-Ranging Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/ Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With Sofosbuvir (SOF) With and Without Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Naive Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2015-11","completion":"2015-11","firstPosted":"2015-03-26","resultsPosted":"2016-12-12","lastUpdate":"2016-12-12"},"enrollment":10,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Virus (HCV Infection Genotype 1)"],"interventions":[{"type":"DRUG","name":"ombitasvir/paritaprevir/ritonavir, dasabuvir","otherNames":["Viekira PAK","ombitasvir also known as ABT-267","paritaprevir also known as ABT-450","dasabuvir also known as ABT-333"]},{"type":"DRUG","name":"sofosbuvir (SOF)","otherNames":[]},{"type":"DRUG","name":"ribavirin (RBV)","otherNames":[]}],"arms":[{"label":"Ombitasvir/Paritaprevir/r, Dasabuvir, and SOF plus RBV","type":"EXPERIMENTAL"}],"summary":"This open-label study will evaluate the safety and efficacy of co-formulated ombitasvir/paritaprevir/ritonavir and dasabuvir co-administered with sofosbuvir with or without ribavirin administered for either 4 or 6 weeks in treatment naive adults with chronic HCV-genotype 1 infection without cirrhosis","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks (SVR12) Post-treatment","timeFrame":"12 weeks after the last actual dose of study drug","effectByArm":[{"arm":"Ombitasvir/Paritaprevir/r, Dasabuvir, and SOF Plus RBV","deltaMin":80,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":["http://www.rxabbvie.com/"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":10},"commonTop":["FATIGUE","INSOMNIA","UPPER RESPIRATORY TRACT INFECTION","HEADACHE","CONSTIPATION"]}}